Table:
begin	end	state
1	19	cytoplasmic
20	48	transmembrane
49	59	non-cytoplasmic
60	82	transmembrane
83	108	cytoplasmic
109	132	transmembrane
133	141	non-cytoplasmic
142	162	transmembrane
163	168	cytoplasmic
169	186	transmembrane
187	203	non-cytoplasmic
204	225	transmembrane
226	255	cytoplasmic
256	280	transmembrane
281	319	non-cytoplasmic
320	342	transmembrane
343	353	cytoplasmic
354	381	transmembrane
382	388	non-cytoplasmic
389	406	transmembrane
407	413	cytoplasmic
414	441	transmembrane
442	461	non-cytoplasmic
462	486	transmembrane
487	500	cytoplasmic

Input:
>WP_106719518.1 NCBI__GCF_003010935.1:WP_106719518.1
MELLQHLSLGFSVALSPMNLLYCFAGVLLGTFIGVLPGVGPLVTISVLLPLTYGLPPEGA
MIMLAGIYYGAAYGGSTTAILVNLPGESSSAVTCIDGYQMARQGRAGPALAIAAIGSVVA
GCVGTVLIALIGPPLGEVALKFGAAEYCSLMLMALISASALVRGSLVKGMGMAFCGAIFG
LAGTDVNSGIDRFTFGMNGLAEGFDFVVVASGLFAFSEIIANLGVTQHREVLPGQVKNLM
PSREDLKASWKPILRGTGIGAILGVLPGTGQTIASFASYAVERKLAADPSRFGKGAIEGV
AGPESANNAAAQTHFIPTLTLGIPSSATMALLLGALMIQGITPGPQVMTQHPQLFWGLVA
SMWIGNVLLVILNLPLVGVWVTLLKVPYRWLYPLILVFSCIGIYTVNMSSTDVAFAALFG
LIGYIFLKLDCEPAPFILGFLLGPMLEENFRRAMLQSHGDLSVFVTAPLSAIFLAVAFAL
MVMMIFPMIRKRKDQAVTEG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server